We are live on
!
Find out more
AIC
Argus Investors Counsel Portfolio holdings
AUM
$130M
1-Year Est. Return
37.06%
This Fund
S&P 500
This Quarter
Est. Return
+2.98%
1 Year Est. Return
+37.06%
3 Year Est. Return
+123.69%
5 Year Est. Return
+149.89%
10 Year Est. Return
+466.25%
AUM
$150M
AUM Growth
-$3.53M
(-2.3%)
Cap. Flow
-$5.49M
Cap. Flow
% of AUM
-3.67%
Top 10 Holdings %
Top 10 Hldgs %
29.01%
Holding
118
New
7
Increased
28
Reduced
76
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$588K |
| 2 |
Invesco S&P 500 Quality ETF
SPHQ
|
+$438K |
| 3 |
Phillips 66
PSX
|
+$249K |
| 4 |
GE HealthCare
GEHC
|
+$244K |
| 5 |
Dick's Sporting Goods
DKS
|
+$236K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$822K |
| 2 |
Pfizer
PFE
|
+$809K |
| 3 |
Morgan Stanley
MS
|
+$283K |
| 4 |
JPMorgan Chase
JPM
|
+$279K |
| 5 |
Netflix
NFLX
|
+$276K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.61% |
| 2 | Financials | 17.16% |
| 3 | Healthcare | 14.32% |
| 4 | Industrials | 13.86% |
| 5 | Communication Services | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Roper Technologies
ROP
$39.5B
| $353K | 0.24% |
680
-29
| -4% | -$15.9K |
|
102
iShares Core S&P 500 ETF
IVV
$902B
| $351K | 0.23% |
596
-2
| -0.3% | -$1.18K |
|
103
Blackstone
BX
$118B
| $345K | 0.23% |
2,000
+125
| +7% | +$21.8K |
|
104
Ameriprise Financial
AMP
$49.7B
| $330K | 0.22% |
620
+52
| +9% | +$27.8K |
|
105
Merck
MRK
$322B
| $317K | 0.21% |
3,189
+1,097
| +52% | +$113K |
|
106
Royal Caribbean
RCL
$82.1B
| $311K | 0.21% |
1,350
| – | – |
|
|
TBIL
107
F/m US Treasury 3 Month Bill Fund
TBIL
$7.24B
| $311K | 0.21% |
6,233
+174
| +3% | +$8.69K |
|
|
NVO
108
Novo Nordisk
NVO
$207B
| $308K | 0.21% |
3,579
+475
| +15% | +$51.4K |
|
109
T-Mobile US
TMUS
$192B
| $264K | 0.18% |
1,196
+98
| +9% | +$22.3K |
|
|
110
Dick's Sporting Goods
DKS
$18.4B
| $257K | 0.17% |
+1,124
| New | +$236K |
|
111
Southern Company
SO
$106B
| $252K | 0.17% |
3,056
+173
| +6% | +$15.2K |
|
112
Norfolk Southern
NSC
$75.2B
| $235K | 0.16% |
1,000
| – | – |
|
113
lululemon athletica
LULU
$14.3B
| $230K | 0.15% |
+602
| New | +$197K |
|
|
114
GE HealthCare
GEHC
$32.9B
| $224K | 0.15% |
+2,871
| New | +$244K |
|
|
115
Phillips 66
PSX
$89.5B
| $223K | 0.15% |
+1,957
| New | +$249K |
|
116
Lockheed Martin
LMT
$138B
| $205K | 0.14% |
421
+2
| +0.5% | +$1.09K |
|
117
ServiceNow
NOW
$132B
| $201K | 0.13% |
+950
| New | +$192K |
|
|
118
Pfizer
PFE
$152B
| – | – |
-27,940
| Closed | -$809K |
|
Similar funds
NCM
CG
EPCA
WM
BM
ECP
HHGC
TIA
Argus Investors Counsel's Q4 2024 Portfolio in Review
As of Q4 2024, Argus Investors Counsel held 118 positions worth $150M, down 2.3% from $153M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Argus Investors Counsel withdrew a net $5.49M in Q4 2024, closing 1 position and reducing 76 holdings. Its most notable exit was Pfizer, an estimated $809K position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Argus Investors Counsel opened a new position in Bank of New York Mellon worth $584K.
- Argus Investors Counsel's largest Q4 2024 buy was Bank of New York Mellon: 7,602 shares worth $584K.
- Argus Investors Counsel added most to iShares MSCI EAFE ETF in Q4 2024, an estimated $161K increase.
- Argus Investors Counsel's biggest Q4 2024 reduction was McKesson, cutting an estimated $822K.
- Argus Investors Counsel fully exited Pfizer in Q4 2024, selling an estimated $809K.
- Argus Investors Counsel's ten largest holdings make up 29% of its $150M portfolio in Q4 2024.
- Argus Investors Counsel opened 7 new positions and closed 1 in Q4 2024.
- Argus Investors Counsel's portfolio value fell 2.3% quarter-over-quarter to $150M.
Based on Argus Investors Counsel's 13F filing for Q4 2024, filed 27 Jan 2025.